Thomas C. Scanlon

489 total citations
17 papers, 383 citations indexed

About

Thomas C. Scanlon is a scholar working on Molecular Biology, Ecology and Infectious Diseases. According to data from OpenAlex, Thomas C. Scanlon has authored 17 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Ecology and 4 papers in Infectious Diseases. Recurrent topics in Thomas C. Scanlon's work include Bacteriophages and microbial interactions (5 papers), Antimicrobial Peptides and Activities (3 papers) and HIV/AIDS Research and Interventions (3 papers). Thomas C. Scanlon is often cited by papers focused on Bacteriophages and microbial interactions (5 papers), Antimicrobial Peptides and Activities (3 papers) and HIV/AIDS Research and Interventions (3 papers). Thomas C. Scanlon collaborates with scholars based in United States, Canada and United Kingdom. Thomas C. Scanlon's co-authors include Karl E. Griswold, Charlotte C. Tenebäck, Laurie W. Leclair, Bruce Gottlieb, Mark Trifiro, Lenore K. Beitel, Matthew J. Wargo, Marcelo Zubarán Goldani, Elizabeth Gray and Andrew Tomkins and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Thomas C. Scanlon

17 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas C. Scanlon United States	11	170	89	67	65	39	17	383
Vahid Lohrasbi Iran	11	201 1.2×	115 1.3×	88 1.3×	60 0.9×	17 0.4×	19	467
Laura J. Dunphy United States	9	158 0.9×	55 0.6×	41 0.6×	13 0.2×	107 2.7×	12	454
Olivier Meunier France	11	168 1.0×	254 2.9×	47 0.7×	24 0.4×	72 1.8×	66	530
Ruiqing Zhang China	11	141 0.8×	142 1.6×	92 1.4×	19 0.3×	25 0.6×	44	400
Monika Adamczyk-Popławska Poland	11	145 0.9×	38 0.4×	38 0.6×	69 1.1×	137 3.5×	26	358
Terry John Evans United Kingdom	13	295 1.7×	55 0.6×	30 0.4×	270 4.2×	58 1.5×	27	583
Sara R. Palmer United States	12	254 1.5×	59 0.7×	17 0.3×	58 0.9×	31 0.8×	18	591
Yifan Rao China	12	241 1.4×	240 2.7×	46 0.7×	28 0.4×	78 2.0×	24	539
Indu Singh India	11	190 1.1×	90 1.0×	38 0.6×	27 0.4×	5 0.1×	40	606
Alexandra B. Sassi United States	10	140 0.8×	161 1.8×	22 0.3×	21 0.3×	209 5.4×	10	562

Countries citing papers authored by Thomas C. Scanlon

Since Specialization

Citations

This map shows the geographic impact of Thomas C. Scanlon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas C. Scanlon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas C. Scanlon more than expected).

Fields of papers citing papers by Thomas C. Scanlon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas C. Scanlon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas C. Scanlon. The network helps show where Thomas C. Scanlon may publish in the future.

Co-authorship network of co-authors of Thomas C. Scanlon

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas C. Scanlon. A scholar is included among the top collaborators of Thomas C. Scanlon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas C. Scanlon. Thomas C. Scanlon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Clark, Nathaniel E., et al.. (2025). Removal of dsRNA byproducts using affinity chromatography. Molecular Therapy — Nucleic Acids. 36(2). 102549–102549. 1 indexed citations

Clark, Nathaniel E., et al.. (2024). An immuno‐northern technique to measure the size of dsRNA byproducts in in vitro transcribed RNA. Electrophoresis. 45(17-18). 1546–1554. 4 indexed citations

Scanlon, Thomas C., et al.. (2015). Genetically Enhanced Lysozyme Evades a Pathogen Derived Inhibitory Protein. ACS Chemical Biology. 10(4). 1110–1117. 9 indexed citations

Griswold, Karl E., et al.. (2014). Bioengineered lysozyme in combination therapies forPseudomonas aeruginosalung infections. Bioengineered. 5(2). 143–147. 25 indexed citations

Scanlon, Thomas C., et al.. (2013). A high‐throughput screen for antibiotic drug discovery. Biotechnology and Bioengineering. 111(2). 232–243. 77 indexed citations

Tenebäck, Charlotte C., et al.. (2013). Bioengineered Lysozyme Reduces Bacterial Burden and Inflammation in a Murine Model of Mucoid Pseudomonas aeruginosa Lung Infection. Antimicrobial Agents and Chemotherapy. 57(11). 5559–5564. 27 indexed citations

Ackerman, Margaret E., et al.. (2011). Genetically Engineered Alginate Lyase-PEG Conjugates Exhibit Enhanced Catalytic Function and Reduced Immunoreactivity. PLoS ONE. 6(2). e17042–e17042. 26 indexed citations

Scanlon, Thomas C., et al.. (2011). Crystal Structure of a Charge Engineered Human Lysozyme Having Enhanced Bactericidal Activity. PLoS ONE. 6(3). e16788–e16788. 24 indexed citations

Scanlon, Thomas C., et al.. (2010). The monoclonal myth. PubMed. 1(3). 225–228. 1 indexed citations

10.

Scanlon, Thomas C., et al.. (2010). Enhanced Antimicrobial Activity of Engineered Human Lysozyme. ACS Chemical Biology. 5(9). 809–818. 41 indexed citations

11.

Scanlon, Thomas C., Elizabeth Gray, & Karl E. Griswold. (2009). Quantifying and resolving multiple vector transformants in S. cerevisiae plasmid libraries. BMC Biotechnology. 9(1). 95–95. 19 indexed citations

12.

Scanlon, Thomas C., Bruce Gottlieb, Thomas M. Durcan, et al.. (2008). Isolation of human proteasomes and putative proteasome-interacting proteins using a novel affinity chromatography method. Experimental Cell Research. 315(2). 176–189. 27 indexed citations

13.

Goldani, Marcelo Zubarán, et al.. (2006). Barriers for HIV testing during pregnancy in Southern Brazil. Revista de Saúde Pública. 40(2). 220–225. 10 indexed citations

14.

Beitel, Lenore K., Thomas C. Scanlon, Bruce Gottlieb, & Mark Trifiro. (2005). Progress in spinobulbar muscular atrophy research: Insights into neuronal dysfunction caused by the polyglutamine-expanded androgen receptor. Neurotoxicity Research. 7(3). 219–230. 17 indexed citations

15.

Goldani, Marcelo Zubarán, et al.. (2003). Voluntary HIV counseling and testing during prenatal care in Brazil Aconselhamento e testagem voluntária para o HIV durante a assistência pré-natal. SHILAP Revista de lepidopterología. 2 indexed citations

16.

Goldani, Marcelo Zubarán, et al.. (2003). Voluntary HIV counseling and testing during prenatal care in Brazil. Revista de Saúde Pública. 37(5). 552–558. 37 indexed citations

17.

Townson, Simon, et al.. (2000). Antibiotics andWolbachiain filarial nematodes: antifilarial activity of rifampicin, oxytetracycline and chloramphenicol againstOnchocerca gutturosa,Onchocerca lienalisandBrugia pahangi. Annals of Tropical Medicine and Parasitology. 94(8). 801–816. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact